Industry AI Adoption Leaderboard

Top AI-ready Manufacturing companies — 4,515 ranked

Ranked leaderboard of 4,515 Manufacturing companies by Meo AI adoption score.

4515

Companies Scored

Avg Adoption Score

Advanced

Top Stage

Which 4,515 ranked companies lead in AI adoption?

What is the average AI adoption score in the 4,515 ranked industry?
Who are the top 10 AI adopters in 4,515 ranked?

#	Company	Stage	Key Opportunity	Location	Marketing audit
1	Red Nucleus	Advanced	Automated Clinical Trial Document Generation and Review	Yardley, Pennsylvania	Free audit →
2	Cellares	Advanced	Automated Clinical Trial Document Review and Data Extraction	South San Francisco, California	Free audit →
3	merck	Advanced	Accelerating drug discovery and development by using generative AI to design novel molecules and predict clinical trial outcomes.	rahway, New Jersey	Free audit →
4	the janssen pharmaceutical companies of johnson & johnson	Advanced	AI can dramatically accelerate drug discovery and clinical trial design by predicting molecular interactions and optimizing patient recruitment, reducing time-to-market for new therapies.	raritan, New Jersey	Free audit →
5	astra zeneca lp us	Advanced	AI can dramatically accelerate drug discovery and clinical trial design by predicting molecular interactions and optimizing patient recruitment, reducing time-to-market for new therapies.	wilmington, Delaware	Free audit →
6	pfizerpro	Advanced	AI can accelerate drug discovery and clinical trial optimization, reducing development timelines from years to months and saving billions in R&D costs.	new york, New York	Free audit →
7	starkindustries2, ltds.	Advanced	AI-driven molecular simulation and materials discovery can drastically accelerate R&D cycles and reduce costs for new nanotechnology products.	watertown, New York	Free audit →
8	pfizer	Advanced	AI can dramatically accelerate drug discovery by predicting molecular interactions and optimizing clinical trial design, potentially cutting years and billions from R&D timelines.	new york, New York	Free audit →
9	vertex pharmaceuticals	Advanced	AI can dramatically accelerate target identification and compound optimization for novel genetic disease therapies, compressing years of research into months.	boston, Massachusetts	Free audit →
10	monsanto company	Advanced	AI-driven predictive modeling can optimize the genetic selection and field trial process for new seed and trait development, dramatically accelerating R&D cycles and improving yield predictability under varying climate conditions.	st. louis, Missouri	Free audit →
11	msd	Advanced	AI can dramatically accelerate drug discovery and clinical trial design by predicting molecular interactions and optimizing patient recruitment, potentially saving billions in R&D costs and years in development timelines.	rahway, New Jersey	Free audit →
12	eli lilly and company	Advanced	AI can accelerate drug discovery by predicting molecular interactions and optimizing clinical trial design, dramatically reducing time-to-market for new therapies.	indianapolis, Indiana	Free audit →
13	Vanigent	Advanced	Automated Clinical Trial Patient Recruitment & Screening	Atlanta, Georgia	Free audit →
14	The Cary Company	Advanced	Automated Inventory Management and Replenishment Forecasting	Addison, Illinois	Free audit →
15	Amplity	Advanced	Automated Medical Information Request Handling	Langhorne, Pennsylvania	Free audit →
16	Lantheus	Advanced	Automated Clinical Trial Patient Recruitment and Screening	Bedford, Massachusetts	Free audit →
17	amgen	Advanced	AI can dramatically accelerate drug discovery and clinical trial design by predicting protein structures, identifying novel therapeutic targets, and optimizing patient recruitment, potentially cutting years and billions from R&D timelines.	thousand oaks, California	Free audit →
18	Walsworth	Advanced		Brookfield, Missouri	Free audit →
19	Myers Industries	Advanced		Akron, Ohio	Free audit →
20	MFA Oil	Advanced		Columbia, Missouri	Free audit →
21	IWCO	Advanced		Chanhassen, Minnesota	Free audit →
22	Resource Label Group	Advanced		Franklin, Tennessee	Free audit →
23	bristol myers squibb	Advanced	AI can accelerate drug discovery and clinical trials by predicting molecular interactions, optimizing trial design, and identifying patient cohorts, dramatically reducing the time and cost of bringing new therapies to market.	lawrence township, New Jersey	Free audit →
24	procter & gamble	Advanced	AI-driven demand sensing and dynamic supply chain optimization can significantly reduce stockouts and inventory costs across its global portfolio of fast-moving consumer goods.	cincinnati, Ohio	Free audit →
25	Alleguard	Advanced		brentwood, Tennessee	Free audit →
26	Takeda Oncology	Advanced		Cambridge, Massachusetts	Free audit →
27	avantor	Advanced	AI-driven supply chain optimization and predictive quality control for high-purity materials can reduce waste and improve on-time delivery.	radnor, Pennsylvania	Free audit →
28	RelaDyne	Advanced		Cincinnati, Ohio	Free audit →
29	NYSCC	Advanced		New York, New York	Free audit →
30	iff	Advanced	Accelerate novel flavor and fragrance molecule discovery with generative AI, cutting R&D cycle time by 30–50% while optimizing for cost, sustainability, and regulatory compliance.	new york, New York	Free audit →
31	Fagron US	Advanced	Automated Prior Authorization Processing	Austin, Texas	Free audit →
32	PBF Energy	Advanced		Parsippany-Troy Hills, New Jersey	Free audit →
33	itw	Advanced	Deploy AI-driven predictive maintenance across global manufacturing lines to reduce unplanned downtime and optimize equipment effectiveness.	,	Free audit →
34	ProVia	Advanced		Sugarcreek, Ohio	Free audit →
35	abbvie	Advanced	AI-driven target discovery and clinical trial optimization can dramatically accelerate drug development pipelines and reduce multi-billion-dollar R&D costs.	north chicago, Illinois	Free audit →
36	Federal	Moderate		Springfield, Illinois	Free audit →
37	Sinclair Oil	Moderate		, null	Free audit →
38	BEHR	Moderate		Santa Ana, California	Free audit →
39	Valvoline™ Global	Moderate		lexington, Kentucky	Free audit →
40	Libertycoke	Moderate		Philadelphia, Pennsylvania	Free audit →
41	North Sails	Moderate		Newport, Rhode Island	Free audit →
42	Mannington	Moderate		Salem, New Jersey	Free audit →
43	regeneron	Moderate	AI can accelerate Regeneron's core R&D by predicting drug-target interactions and patient response biomarkers, drastically reducing the time and cost of bringing new biologics to market.	tarrytown, New York	Free audit →
44	Prognos Health	Moderate	Automated Clinical Trial Patient Matching and Outreach	New York, New York	Free audit →
45	medivation	Moderate	Leveraging generative AI to accelerate clinical trial patient recruitment and optimize oncology drug trial protocols, reducing time-to-market by up to 30%.	new york, New York	Free audit →
46	dupont	Moderate	AI can accelerate the discovery and formulation of new sustainable materials by predicting molecular properties and optimizing synthesis pathways, drastically reducing R&D timelines.	wilmington, Delaware	Free audit →
47	sanofi genzyme	Moderate	AI can accelerate drug discovery for rare diseases by predicting molecular interactions and optimizing clinical trial design, drastically reducing development timelines and costs.	cambridge, Massachusetts	Free audit →
48	daiichi sankyo us	Moderate	AI can accelerate oncology drug discovery by predicting compound efficacy and optimizing clinical trial designs, reducing time-to-market for life-saving therapies.	basking ridge, New Jersey	Free audit →
49	gilead sciences	Moderate	AI can dramatically accelerate drug discovery and clinical trial design by predicting molecular interactions and identifying optimal patient cohorts.	foster city, California	Free audit →
50	bristol-myers squibb	Moderate	Leveraging generative AI to accelerate clinical trial document generation and regulatory submission drafting, reducing cycle times by 30-40% for a mid-market pharma firm.	seattle, Washington	Free audit →
51	egpi	Moderate	Leveraging AI for accelerated drug discovery and predictive analytics in clinical trials to reduce time-to-market and R&D costs.	torrance, California	Free audit →
52	thermo fisher scientific	Moderate	AI can accelerate drug discovery and diagnostics by analyzing vast genomic and proteomic datasets to identify novel biomarkers and therapeutic targets, dramatically reducing R&D timelines.	waltham, Massachusetts	Free audit →
53	johnson & johnson	Moderate	AI can accelerate drug discovery and clinical trials by predicting molecular interactions and optimizing patient recruitment, dramatically reducing time-to-market and R&D costs.	new brunswick, New Jersey	Free audit →
54	Atmus	Moderate		nashville, Tennessee	Free audit →
55	Voyant Beauty	Moderate		Lyons Township, Illinois	Free audit →
56	Lannett	Moderate		Philadelphia, Pennsylvania	Free audit →
57	PAHC	Moderate		Teaneck Township, New Jersey	Free audit →
58	dow	Moderate	AI-driven predictive maintenance and process optimization in large-scale chemical plants can significantly reduce unplanned downtime, improve yield, and enhance safety.	midland, Michigan	Free audit →
59	medformers	Moderate	Leverage AI for accelerated drug discovery and clinical trial optimization to reduce time-to-market and R&D costs.	new york, New York	Free audit →
60	Drug Plastics & Glass Co., Inc.	Moderate		boyertown, Pennsylvania	Free audit →
61	schering-plough research institute	Moderate	AI can accelerate drug discovery by predicting molecular interactions and optimizing clinical trial design, dramatically reducing time-to-market for new therapeutics.	kenilworth, New Jersey	Free audit →
62	TP Orthodontics	Moderate		La Porte, Indiana	Free audit →
63	celgene	Moderate	AI-driven drug discovery and clinical trial optimization can significantly accelerate time-to-market for novel therapies while reducing R&D costs.	summit, New Jersey	Free audit →
64	YAK MAT	Moderate		Columbia, Mississippi	Free audit →
65	Alaffia	Moderate		Olympia, Washington	Free audit →
66	milliporesigma	Moderate	AI can accelerate drug discovery and bioprocess optimization by predicting experimental outcomes, analyzing complex multi-omics data, and automating the design of novel reagents and assays.	burlington, Massachusetts	Free audit →
67	p&g pharmaceuticals	Moderate	AI-driven target discovery and clinical trial optimization can dramatically accelerate drug development cycles and reduce multi-billion-dollar R&D costs.	,	Free audit →
68	Sprague	Moderate		Portsmouth, New Hampshire	Free audit →
69	iveric bio, an astellas company	Moderate	Leverage AI-powered analysis of retinal imaging and real-world data to accelerate clinical development and personalize treatment for geographic atrophy.	parsippany, New Jersey	Free audit →
70	radim spa	Moderate	Leverage AI for accelerated drug discovery and predictive quality control to reduce time-to-market and improve manufacturing efficiency.	,	Free audit →
71	Vireo	Moderate		minneapolis, Minnesota	Free audit →
72	Rhino Linings	Moderate		San Diego, California	Free audit →
73	biogen	Moderate	AI can accelerate drug discovery and clinical trial design for complex neurological diseases by predicting drug-target interactions and identifying optimal patient cohorts.	cambridge, Massachusetts	Free audit →
74	incyte	Moderate	AI can accelerate oncology drug discovery by predicting compound efficacy and patient response biomarkers, dramatically reducing R&D timelines and costs.	wilmington, Delaware	Free audit →
75	TemperPack	Moderate		Richmond, Virginia	Free audit →
76	patheon	Moderate	AI can optimize end-to-end drug development and manufacturing processes, from predictive formulation design to real-time quality control, significantly reducing time-to-market and production costs for client therapies.	waltham, Massachusetts	Free audit →
77	ironshore	Moderate	Leveraging AI for accelerated drug discovery and clinical trial optimization to reduce time-to-market and R&D costs.	,	Free audit →
78	kelly engineering service at dow chemical	Moderate	AI-driven predictive maintenance and process optimization can significantly reduce unplanned downtime, improve yield, and enhance safety across large-scale chemical manufacturing complexes.	houston, Texas	Free audit →
79	mylan	Moderate	AI can optimize complex global supply chains and production schedules to reduce costs and prevent drug shortages.	canonsburg, Pennsylvania	Free audit →
80	alnylam pharmaceuticals	Moderate	AI can accelerate target identification and validation for RNAi therapeutics by analyzing multi-omics data to predict gene-disease associations and optimize siRNA design.	cambridge, Massachusetts	Free audit →
81	Fralock	Moderate		Santa Clarita, California	Free audit →
82	ecolab	Moderate	AI-powered predictive maintenance and chemical dosing for water treatment and cleaning systems, optimizing resource use and preventing equipment failures.	st. paul, Minnesota	Free audit →
83	catalent	Moderate	AI can optimize complex biologics manufacturing processes, predict batch failures, and accelerate formulation development, directly improving yield, quality, and time-to-market.	tampa, Florida	Free audit →
84	LIFOAM	Moderate		Greer, South Carolina	Free audit →
85	imclone systems, a wholly-owned subsidiary of eli lilly and company	Moderate	AI can accelerate oncology drug discovery and clinical trial design by predicting drug-target interactions and optimizing patient stratification for therapies like Erbitux.	,	Free audit →
86	Berkshire Corporation	Moderate		Great Barrington, Massachusetts	Free audit →
87	supernus pharmaceuticals, inc.	Moderate	Leveraging AI for drug discovery and clinical trial optimization to accelerate CNS pipeline development and reduce R&D costs.	rockville, Maryland	Free audit →
88	p&g chemicals	Moderate	AI-driven predictive modeling can optimize complex chemical synthesis processes, reducing energy consumption, minimizing waste, and accelerating R&D for new sustainable formulations.	cincinnati, Ohio	Free audit →
89	millennium pharmaceuticals, inc.	Moderate	AI-driven target discovery and patient stratification can dramatically accelerate the development of novel oncology therapies and improve clinical trial success rates.	cambridge, Massachusetts	Free audit →
90	Porex	Moderate		Fairburn, Georgia	Free audit →
91	sanofi-aventis u.s. llc	Moderate	AI can dramatically accelerate drug discovery and clinical trial design by predicting molecular interactions and optimizing patient recruitment, potentially cutting years and billions from R&D timelines.	bridgewater, New Jersey	Free audit →
92	viatris	Moderate	AI can optimize the end-to-end pharmaceutical supply chain, from predictive demand forecasting to dynamic inventory management, reducing costs and preventing drug shortages.	pittsburgh, Pennsylvania	Free audit →
93	Polytex	Moderate		Ponte Vedra, Florida	Free audit →
94	HellermannTyton	Moderate		Tlaquepaque, Jalisco	Free audit →
95	ColorMasters	Moderate		Albertville, Alabama	Free audit →
96	Nutraceutical	Moderate		Park City, Utah	Free audit →
97	ENTEK	Moderate		Lebanon, Oregon	Free audit →
98	Bgintr	Moderate		union, New Jersey	Free audit →
99	Sierra Nevada Corporation	Moderate		Sparks, Nevada	Free audit →
100	Kimia Farma Apotek	Moderate		Jakarta Special Capital Region, New York	Free audit →

See your marketing from the outside.

Get a free marketing audit from public information, separate from the AI adoption scores above.